DuChemBIO Co.,Ltd. (KOSDAQ:176750)

DuChemBIO Statistics

Total Valuation

DuChemBIO has a market cap or net worth of KRW 285.43 billion. The enterprise value is 288.61 billion.

Market Cap	285.43B
Enterprise Value	288.61B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

DuChemBIO has 28.34 million shares outstanding.

Current Share Class	28.34M
Shares Outstanding	28.34M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.96%
Owned by Insiders (%)	9.36%
Owned by Institutions (%)	n/a
Float	10.45M

Valuation Ratios

The trailing PE ratio is 38.38 and the forward PE ratio is 18.21.

PE Ratio	38.38
Forward PE	18.21
PS Ratio	7.97
PB Ratio	6.37
P/TBV Ratio	10.80
P/FCF Ratio	43.48
P/OCF Ratio	35.38
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.45, with an EV/FCF ratio of 43.97.

EV / Earnings	39.76
EV / Sales	8.06
EV / EBITDA	25.45
EV / EBIT	51.45
EV / FCF	43.97

Financial Position

The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.36.

Current Ratio	1.72
Quick Ratio	1.64
Debt / Equity	0.36
Debt / EBITDA	1.52
Debt / FCF	2.48
Interest Coverage	5.30

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	9.56%
Revenue Per Employee	284.25M
Profits Per Employee	57.61M
Employee Count	115
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-2.11B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.68% in the last 52 weeks. The beta is -0.03, so DuChemBIO's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-25.68%
50-Day Moving Average	10,334.60
200-Day Moving Average	11,333.35
Relative Strength Index (RSI)	42.47
Average Volume (20 Days)	50,546

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DuChemBIO had revenue of KRW 35.81 billion and earned 7.26 billion in profits. Earnings per share was 262.40.

Revenue	35.81B
Gross Profit	12.12B
Operating Income	4.99B
Pretax Income	5.15B
Net Income	7.26B
EBITDA	10.72B
EBIT	4.99B
Earnings Per Share (EPS)	262.40

Balance Sheet

The company has 13.08 billion in cash and 16.26 billion in debt, giving a net cash position of -3.18 billion or -112.29 per share.

Cash & Cash Equivalents	13.08B
Total Debt	16.26B
Net Cash	-3.18B
Net Cash Per Share	-112.29
Equity (Book Value)	44.78B
Book Value Per Share	1,579.81
Working Capital	10.80B

Cash Flow

In the last 12 months, operating cash flow was 8.07 billion and capital expenditures -1.50 billion, giving a free cash flow of 6.56 billion.

Operating Cash Flow	8.07B
Capital Expenditures	-1.50B
Free Cash Flow	6.56B
FCF Per Share	231.60

Margins

Gross margin is 33.85%, with operating and profit margins of 13.93% and 20.27%.

Gross Margin	33.85%
Operating Margin	13.93%
Pretax Margin	14.37%
Profit Margin	20.27%
EBITDA Margin	29.93%
EBIT Margin	13.93%
FCF Margin	18.33%

Dividends & Yields

DuChemBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	2.54%
FCF Yield	2.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DuChemBIO has an Altman Z-Score of 10.54 and a Piotroski F-Score of 3.

Altman Z-Score	10.54
Piotroski F-Score	3